Enantiomerically Pure α-Amino Aldehydes from Silylated α-Amino Acids
摘要:
The disilylation of alpha-amino acids 1 to provide 2 (72-87%) was achieved without racemization. An unprecedented borane-mediated semi-reduction strategy was devised to convert 2 to stable, isolable oxazaborolidines 3 (100%) which were hydrolyzed to provide 5 (49-60%) as pure, stable compounds. Analysis of the Mosher amides (8) of the gamma-amino esters 7 reveals that <= 2% racemization occurs in the 1 -> 8 conversions.
Enantiomerically Pure α-Amino Aldehydes from Silylated α-Amino Acids
摘要:
The disilylation of alpha-amino acids 1 to provide 2 (72-87%) was achieved without racemization. An unprecedented borane-mediated semi-reduction strategy was devised to convert 2 to stable, isolable oxazaborolidines 3 (100%) which were hydrolyzed to provide 5 (49-60%) as pure, stable compounds. Analysis of the Mosher amides (8) of the gamma-amino esters 7 reveals that <= 2% racemization occurs in the 1 -> 8 conversions.
[EN] NOVEL N-ACETYL-L-LEUCYL-L-LEUCYL-L-NORLEUCINAL (ALLN) DERIVATIVE COMPOUND, COMPOSITION FOR PREVENTING OR TREATING MALARIA, CONTAINING SAME AS ACTIVE INGREDIENT, AND USE THEREOF<br/>[FR] NOUVEAU COMPOSÉ DÉRIVÉ N-ACÉTYL-L-LEUCYL-L-LEUCYL-L-NORLEUCINAL (ALLN), COMPOSITION POUR LA PRÉVENTION OU LE TRAITEMENT DU PALUDISME, CONTENANT LEDIT COMPOSÉ UTILISÉ COMME PRINCIPE ACTIF, ET SON UTILISATION
申请人:WONKWANG UNIV CT IND ACAD COOP
公开号:WO2014084471A1
公开(公告)日:2014-06-05
본 발명은 ALLN 유도체 화합물을 유효성분으로 함유하는 항 말라리아 조성물에 관한 것으로, 본 발명의 화합물들은 ALLN (N-acetyl-L-Leucyl-Lleucyl-L-norleucinal) 유도체 화합물을 유효성분으로 함유하는 말라리아 감염 질환의 예방 및 치료용 약학조성물로 사용할 수 있다.